STERIS AST — Payments to Acquire Productive Assets remained flat by 0.0% to $59.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from $56.80M to $59.60M. Over 2 years (FY 2024 to FY 2026), AST — Payments to Acquire Productive Assets shows relatively stable performance with a 0.3% CAGR.
An increase suggests active investment in capacity expansion or facility modernization, while a decrease may indicate a period of maintenance-only spending or reduced capital allocation to the segment.
This metric represents the cash outflows dedicated to the acquisition, construction, or improvement of long-term physica...
Comparable to capital expenditures (CapEx) reported by peers in medical device contract manufacturing or industrial sterilization services, typically benchmarked as a percentage of segment revenue.
ste_segment_ast_payments_to_acquire_productive_assets| FY'24 | FY'25 | FY'26 | |
|---|---|---|---|
| Value | $237.00M | $227.20M | $238.40M |
| YoY Change | — | -4.1% | +4.9% |